AI Terminal
Malin Corporation Plc
Pre-Annual General Meeting Information • Jan 15, 2021
1959_egm_2021-01-15_1e6b9109-31a6-446d-a9b8-c6643a404405.html
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8598L
Malin Corporation PLC
15 January 2021
Malin Corporation plc
Notice of Extraordinary General Meeting
Dublin-Ireland, 15 January 2021: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin", the "Company"), a company investing in highly innovative life sciences companies, announces that an Extraordinary General Meeting of the Company will be held at The Lennox Building, 50 Richmond Street South, Dublin D02 FK02, Ireland at 10:00am GMT on Wednesday, 10 February 2021 (the "EGM").
The business of the EGM will be to consider and, if thought fit, approve certain resolutions relating to the replacement of CREST with a system operated by Euroclear Bank SA/NV for the electronic settlement of trading in the Company's ordinary shares (the "Resolutions"). Approval of the Resolutions is necessary to ensure the Company's shares can continue to be settled electronically when they are traded on Euronext Growth Dublin and remain eligible for continued admission to trading and listing on Euronext Growth Dublin, which is crucial to the interests of the Company and its shareholders as a whole.
The circular which includes the Notice of the EGM (the "Circular") and a Form of Proxy have been issued to shareholders today. The board of the Company strongly urges shareholders to review the contents of the Circular in their entirety, including the documents referred to therein, and consider its recommendation to vote in favour of the Resolutions.
The Circular, Form of Proxy and copies of the documents referred to in the Circular are available to view on the Company's website at www.malinplc.com and will be available for inspection during normal business hours on any business day from the date of the Circular until the conclusion of the EGM at the registered office of the Company.
As detailed in the Notice of EGM, in the interests of public health and in light of guidance from the Government of Ireland relating to the ongoing COVID‑19 pandemic, all shareholders are encouraged to submit proxy forms to ensure they can vote and be represented at the EGM without having to physically attend the meeting.
In addition, a teleconference facility will be available to shareholders to listen remotely to the proceedings of the EGM, using the following details:
From Ireland dial: 01 5369584
From the UK dial: 020 3936 2999
From the USA dial: 1 845 213 3398
From other locations dial: +44 20 3936 2999
Listen‑Only Access Code: 347523
A replay of the meeting will be accessible for one month following the date of the EGM on the Company's website at www.malinplc.com.
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long‑term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com
For further information, please contact:
Malin
Fiona Dunlevy, Company Secretary
Tel: +353 (0)1 901 5700
Davy Corporate Finance (Euronext Growth Adviser & Joint Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Liberum (Joint Broker)
Bidhi Bhoma / Euan Brown
Tel: +44 (0) 20 3100 2000
Powerscourt (Irish media enquiries)
Eavan Gannon
Tel: +353 87 236 5973
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOGGPUUAGUPGGUA